Similarly, endometrial cell lines were sensitized to TriC by the addition of omega‐3 FA docosahexaenoic acid (DHA), suggesting that combinations of TriC with other metabolic effectors or therapies may increase the relevance of TriC or ACSL‐targeting therapies in myeloma [23]. The gene discussed is MARVELD2; the disease is plasma cell myeloma.